A glutathione-responsive L-carnitine-modified camptothecin oral nano-prodrug for cancer therapy
Min Hong(Liaocheng University), Chenzhong Li(Chinese University of Hong Kong), Qinghong Ji(Liaocheng University), Shuang Cheng(Liaocheng University), Haobin Chen(Washington University in St. Louis), Lei Li(Liaocheng University), Xiaoyan Liu(Wuhan University)
Cited by 1
Related Papers
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025
|Nucleic Acids Research|2024|362
Radical aryl migration enables diversity-oriented synthesis of structurally diverse medium/macro- or bridged-rings
|Nature Communications|2016|192
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
|Cell Reports Medicine|2020|186
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
|Journal of Clinical Oncology|2017|177
Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium
|Toxicology and Applied Pharmacology|2009|166